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Available online 30 May 2017Intracardiac haemodynamics is crucial for normal cardiogenesis, with recent evidence showing valvulogenesis is
haemodynamically dependent and inextricably linkedwith shear stress. Although valve anomalies have been as-
sociated with genetic mutations, often the cause is unknown. However, altered haemodynamics have been sug-
gested as a pathogenic contributor to bicuspid aortic valve disease. Conversely, how abnormal haemodynamics
impacts mitral valve development is still poorly understood. In order to analyse altered blood ﬂow, the outﬂow
tract of the chick heart was constricted using a ligature to increase cardiac pressure overload. Outﬂow tract-
banding was performed at HH21, with harvesting at crucial valve development stages (HH26, HH29 and
HH35). Although normal valve morphology was found in HH26 outﬂow tract banded hearts, smaller and dys-
morphicmitral valve primordiawere seenupon altered haemodynamics in histological and stereological analysis
at HH29 and HH35. A decrease in apoptosis, and aberrant expression of a shear stress responsive gene and extra-
cellular matrix markers in the endocardial cushions were seen in the chick HH29 outﬂow tract banded hearts. In
addition, dysregulation of extracellular matrix (ECM) proteins ﬁbrillin-2, type III collagen and tenascin were fur-
ther demonstrated inmoremature primordial mitral valve leaﬂets at HH35,with a concomitant decrease of ECM
cross-linking enzyme, transglutaminase-2. These data provide compelling evidence that normal haemodynamics
are a prerequisite for normalmitral valvemorphogenesis, and abnormal blood ﬂow could be a contributing factor
in mitral valve defects, with differentiation as a possible underlying mechanism.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Amature heart has four cardiac valves; pulmonary and aortic valves
(semilunar valves) and tricuspid (TV) andmitral valves (MV) (right and
left atrioventricular valves, respectively). These valves ensure unidirec-
tional blood ﬂow to both pulmonary and systemic systems. Aberrant
developmental mechanisms can occur and give rise to congenital
valve defects [1]. Congenital valve malformations have a prevalence of
2% of live births and occur in a number of genetic syndromes such as
Marfan syndrome and trisomy21, and can happen in isolation or in con-
junction with other heart defects including hypoplastic left heart syn-
drome and Tetralogy of Fallot [1–3]. Congenital MV anomalies were
detected in 0.5% of 13,400 subjects in an echocardiographic study and
are susceptible to subtle developmental abnormalities [4]. Although
MV anomalies such as myxomatous valve disease, MV atresia, stenosis
and prolapse often have an unknown aetiology, they have also been as-
sociated with mutations in ﬁbrillin-1, ﬁlamin A and NOTCH1 [5–9]. It is. Loughna).
. This is an open access article underknown that haemodynamics plays an important role in normal valve
morphogenesis and is associated with shear stress [10–13]. In recent
years, the alteration of haemodynamics has been proposed to be a path-
ogenic contributor to valve defects [14,15]. Absent atrioventricular (AV)
valves were seen upon occlusion of haemodynamics in zebraﬁsh [10],
whereas constriction of blood ﬂow by placing a ligature around the out-
ﬂow tract (OFT-banding) increased mitral-aortic valve separation and
valve regurgitation as well as affected OFT valve development in chick
[16–19]. With regards the tricuspid valve, immature or abnormal TV
valves were found upon morphological analysis of banded hearts in
the chick [20,21].
The heart is the ﬁrst organ to form as a linear tube and it consists of
outer myocardium and inner endocardium which sandwich a layer of
extracellular matrix (ECM) called cardiac jelly [3]. During looping of
the chick heart tube at HH14, valvulogenesis initiates with ECM swell-
ings that expand at the atrioventricular canal (AVC) and OFT, forming
the endocardial cushions (EC), which act as primitive valves [22,23].
ECs form when a subset of endocardial cells lose intercellular adhesion
and migrate into AV cushion mesenchyme, by endocardial-mesenchy-
mal transformation (EMT) [22]. Subsequent growth and septation take
place as the superior and inferior EC fuse to produce the centralthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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mal protrusion and mesenchymal cap at the inferior part of the atrial
septum primum at HH24 and the upper portion of the ventricular sep-
tum at HH29/30 to fully septate the primitive atria and ventricles into
four chambers [25–29].
During post-EMT (from HH26), distal outgrowth and maturation of
the ECs take place via migration, apoptosis and proliferation with the
expression of ECM proteins [30]. In addition, valve-associated ﬁbrous
structures such as chordae tendinae form and the cushion mesenchy-
mal cells differentiate into valvular interstitial ﬁbroblasts [31]. The
remodelled AV valve primordia eventually develop into mature struc-
tures with three stratiﬁed layers containing different ECM components;
atrialis (ﬁbrillin-1, ﬁbrillin-2, ﬁbronectin), spongiosa (perlecan,
aggrecan) and ﬁbrosa (collagen type I and III, tenascin) [32,33]. Each
layer has a speciﬁed role in withstanding the mechanical load in the
heart [32–35]. With regards the valve leaﬂets, the septal leaﬂets of the
TV form by delamination from themuscular ventricular septum,where-
as the MV septal leaﬂets form by elongation and protrusion of the cush-
ion mesenchyme into the ventricular lumen [36,37]. The lateral leaﬂets
form due to proliferation of the AV mesenchyme from the lateral myo-
cardial wall [38].
Herein, our aim was to characterize the effect of altered
haemodynamics on the developing MV at the morphological and mo-
lecular level. In the present study, we describe dysmorphic mitral
valve primordia upon the alteration of haemodynamics using OFT-
banding in the chick. In addition, the deformed HH29 primordial valves
aberrantly expressed shear stress responsive genes alongside genes
encoding ECM proteins, and a decrease in apoptosis was seen, factors
possibly linkedwith failure of differentiation. Dysregulation of ECMpro-
teinswas further demonstrated in primordial valve leaﬂets at later stage
of valve development, with a concomitant decrease of ECM cross-
linking enzyme, transglutaminase-2. We provide evidence of novel
roles for haemodynamics on the developing MV during post-EMT, and
suggest abnormal blood ﬂow as a potential pathogenic contributor to
valve defects.
2. Materials and methods
2.1. Outﬂow tract banding
White fertile chicken eggs (Gallus gallus; Dekalb white strain; Henry
Stewart, UK)were incubated at 38 °C in a humidiﬁed atmosphere under
constant rotation for 4 days until Hamburger and Hamilton stage 21
(HH21) [39]. After windowing, the inner shell membrane was removed
to expose the heart. OFT-bandingwas performed as described using 10-
0 nylon suture [19,21], using a double overhand knot snug around the
OFT. Sham-operated embryos underwent the same procedure but had
the suture removed immediately. Unoperated embryos were win-
dowed, staged, and reincubated. All eggs were sealed and incubated
for an additional 2–5 days until HH26-35. Animal work was performed
in accordance with national (UK home ofﬁce) and institutional regula-
tions and ethical guidelines.
2.2. Embryo isolation
OFT-banded and control (sham and unoperated) embryos were iso-
lated at HH26, HH29 and HH35 and external analysis was performed.
Hearts were then ﬁxed in 4% PFA, washed twice in PBS, dehydrated in
an ethanol series andwax-embedded in a transverse orientation. Unless
otherwise speciﬁed, serial 8 μm sections were taken (DSC1 microtome,
Leica, Germany), dewaxed and rehydrated. For histological studies, sec-
tions were stained with Alcian Blue (Sigma, UK) for 15 min at room
temperature (RT) followed by Mayers haemalum (Raymond Lamb,
UK). Imageswere acquired by a slide scanner (Nanozoomer 2.0-HT, Ha-
mamatsu, Japan).2.3. Stereology and morphometric measurement
Systematic random sampling [40] was used to assess tissue propor-
tions throughout HH29 hearts (control [unoperated and sham] and
OFT-banded; n = 12 controls and n = 7 OFT-banded). A 96-point grid
was placed over every ﬁfth section on the AV valve region which com-
prises the primordial AV septal and lateral leaﬂets in both right and
left sides of the heart. Each point on the AV valve tissue was counted
(223, 218 and 272 points for sham, unoperated and banded, respective-
ly). Average tissue proportions were calculated and tested for statistical
signiﬁcance (see below). For HH29 valve region morphometric mea-
surement, the endocardial cushion (μm2) and the raw length primordial
MV septal leaﬂet (μm) were measured on every third section using
nanozoomer viewing software (NDP.view2). Relative cushion area
was determined by dividing the cushion area of OFT-banded hearts by
that of control heart; valve length was determined using the same pro-
cedure [41]. For quantiﬁcation of embryo size, crown lump length, eye
and eye lens diameter measurements were taken from HH29 embryos
(n = 20) as previously described [42].
2.4. In situ hybridization
Riboprobes for shear stress responsive genes (Krüppel lung factor 2,
KLF2; endothelin 1, EDN1) and ECM markers of endocardial cushion
(versican, VCAN; T-box 20, TBX20) were designed in house. Aggrecan,
periostin and positive control GAPDH sequences were used as previous-
ly reported [43–45]. Primers are listed in Table 1. All riboprobes were
made with incorporation of Digoxigenin (DIG)-UTP (Roche) following
manufacturer's instructions. KLF2, EDN1, TBX20 and aggrecan antisense
probes were synthesized with T7 polymerase from plasmids linearized
with SpeI. VCAN and GAPDH antisense probes were synthesized with
SP6 polymerase from the plasmid linearized with Ncol, with periostin
synthesized with SP6 polymerase from a plasmid linearized with PvuII.
Parafﬁn-embedded neighbouring sections (8 μm) from HH26 and
HH29 hearts were mounted on Superfrost Plus microscope slides (Fish-
er Scientiﬁc) and prepared for in situ hybridization as previously de-
scribed [46] with some modiﬁcations. After deparafﬁnization, sections
were treatedwith 20 μg/mL proteinase K for 8min at RT. After terminat-
ingproteinase K reactionwith glycine (2mg/mL) andpost-ﬁxationwith
4% PFA, sections were acetylated 10 min in 0.25% acetic anhydride in
0.1M triethanolamine pH 8.0. Sectionswere pre-incubatedwith the hy-
bridization mixture (50% formamide, 5 X SSC, 1 X Denhardt's solution,
10% Dextran sulfate, 0.1% Tween-20, 50 μg/mL Heparin, 1 mg/mL
tRNA) for 2 h at 67 °C, and reacted overnight at 67 °C with DIG-label
RNA probes (4–7 μL) added to the hybridization mix. After post hybrid-
ization washes and blocking steps, the sections were incubated over-
night at 4 °C with alkaline phosphatase-conjugated DIG antibody
(1:2000, Roche). Sections were stained with BM purple at RT for colour
development and mounted for imaging using Axioplan microscope
(Zeiss).
2.5. Quantitative PCR analysis
Snap frozen hearts and isolated AV canals were placed at −80 °C
upon harvesting at HH29 and HH35. Total RNA was extracted using
Trizol reagent (Sigma), and treated with RNase-free DNase I (Qiagen),
followed by ﬁrst strand cDNAs synthesis. 1 μg of RNA was used in
each reaction. Each cDNA sample was diluted 4 times with nuclease-
free water before determination of the dynamic range of sample con-
centrations for the qPCR experiment. Stock was diluted 1:33 and 4uL
of this was added to ﬁnal relative quantitation experiment. This dilution
represents values mid-range of the slope in the standard curve optimi-
sations. Optimization of primer concentrations for relative quantitation
and qPCRwere performed using the Applied Biosystems 7500 Fast Real-
time PCR system as previously described [47]. Efﬁciencies of all gene re-
actions were 94.2–106%, with r2-values N 0.98. All samples were run in
Table 1
Primers pairs and annealing temperatures with amplicon size designed for riboprobe synthesis.
Primer GenBank accession number Primer sequence (5′ to 3′) Product size (bp) Annealing temp (°C)
Forward/reverse
KLF2 NM_001318423 ATGGTGAATGACTGCCACAC 515 62
ATGTGCCGCTTCATGTGC
EDN1 XM_418943.4 GAAGTGAACGCCGCATCG 528 62
GCTTTTCCAGATGCTTTGCC
TBX20 NM_204144.1 AGATATGCCTACCACCGCTC 783 62
ATGGTACCTTGGCATGTGGA
Aggrecan NM_204955.2 CTGCGTTCCCTGAGATTAC 963 62
TTGCCAGGTCGATCTCAC
Periostin NM_001030541 TAATGCTCTCCACCACCACA 1001 57.8
TCTGCTGGCTTGATGATTTG
VCAN NM_204787 GCAACAAACAATACAGCCCC 508 62
CTCTCTCAGCCGTATCCCAG
GAPDH NM_204305.1 GGGCTCATCTGAAGGGTGGTGCTA 810 62
GTGGGGGAGACAGAAGGGAACAGA
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consisted of 10 μL of iTaq™ universal SYBR® Green supermix (1×), 0.5
or 0.75 μL of each forward and reverse primer (250 or 375 nM) for KLF2,
periostin, aggrecan, EDN1, TBX20, transglutaminase 2 (TGM2), ﬁbrillin 2
(FBN2), collagen type III alpha 1 chain (COL3A1), tenascin C (TNC) and 4
μL of diluted cDNA template dependant on individual genes (Table 2).
Relative gene expression was quantiﬁed against GAPDH and EEF1A1 as
reference genes. qPCR was performed on isolated AV canals for KLF2 at
HH29 and TGM2, FBN2, COL3A1, TNC at HH35. Otherwise, the qPCR
was done in whole hearts for the remaining genes at HH35.2.6. Apoptosis
ApopTag Peroxidase In Situ Apoptosis Detection Kit S7100
(Millipore, USA) was used to indicate apoptotic cells in accordance
with manufacturer's instructions on 5 μM serial sections. Imaging was
performed using Zeiss Axio Scan Z1. Systematic random sampling [40]
was utilised to count positive cells against total cell count in the endo-
cardial cushions, primordial MV and TV septal and lateral leaﬂets to cal-
culate proportions of apoptotic cells for statistical analysis (see below).
A total of 224,749 cells were identiﬁed as either apoptosis ‘positive’ or
‘negative’ in OFT-banded hearts at HH29 (n = 5 per group).Table 2
Primers pairs used for qPCR.
Primer GenBank accession number Primer sequence (5′ to
Forward/reverse
KLF2 NM_001318423 GCTTCTACCAGACAAAC
CAGGACTGGCCCATAAC
EDN1 XM_418943.4 GATGTGCCAGCCAGAGA
CAGCCTCCAGCCTCTTCA
TBX20 NM_204144.1 AGATATGCCTACCACCG
TGATGTGGCCATGCTGA
Aggrecan NM_204955.2 CGGCATCTGGACAAGAG
CTCCATTCAGACAGGGG
Periostin NM_001030541 AGAACCTGATCTCATGG
GGGTTGTAAAACGTCAG
TGM2 NM_205448.1 CCAGCCCCACATGGAAC
CCACGCTGTCACCAGTCT
GAPDH NM_204305.1 AGACGGTGGATGGCCCC
ACGGCAGGTCAGGTCAA
EEF1A1 NM_001321516.1 GCTCTAACATGCCCTGGT
TGGCTTCAGGACACCAG
FBN2 XM_004949379.2 GCCCATGTGAGCGGTGT
CACTCGCCCTGTTCCATC
COL3A1 NM_205380 CTGGAAGGGCAGGGAA
GGCATGGCTCTGGTTTCC
TNC NM_205456.4 GCTGAGGGTGGATGGCT
CCCATCAGATTGACTCGG2.7. Fibrosis and immunohistochemical studies
HH35OFT-banded and control heartswere serially sectioned (8 μm),
dewaxed and rehydrated in graded ethanol series and water, with
neighbouring sections placed on adjacent slides to allow for the analysis
of different stains. One set of the sections were mordanted in Bouin's
ﬁxative for 1 h at 56 °C and stained using Trichrome Stain (Masson)
Kit (Sigma) based on manufacturer's instructions. Sections were differ-
entiated in 1% acetic acid followed by dehydration. Images were taken
using an Axioplan microscope (Zeiss).
For ﬂuorescence immunohistochemistry, antigen retrieval was per-
formed (microwaving for 10 min in 10 mM citric acid buffer pH 6.0)
on three sets of neighbouring sections. They were blocked in 10% goat
serum in 1% BSA/PBS for 2 h at RT with primary antibody incubation
overnight at 4 °C. Primary antibodies used were JB3 (ﬁbrillin-2; 1:50;
DSHB, USA) [48], M1-B4 (tenascin; 1:50; DSHB) and 3B2 (type III colla-
gen; 1:25; DSHB). Sections were incubated with secondary antibody
(Alexa 488; 1:100, Molecular Probes; A21121) for 1 h at RT. Nuclei
were counterstained with DAPI (1:1000; Sigma; D9542) and imaging
was performed (Leica DMIRE2). Measurement of the ﬂuorescent inten-
sity (represented by grey values of all pixels within region of interest)
was performed in the primordial MV septal leaﬂet using MetaExpress
software (n=5per group). For the spatial-temporal expression proﬁles3′) Primer concentration (nM) Product size (bp)
CCG 250 233
TGT
GACAA 375 180
TTTTC
CTCCT 375 178
TCCA
ACAGA 250 165
CTTGA
CAACCA 250 183
TGGAATCT
AGA 375 128
CA
TCT 375 263
CAACA
TCAAG 375 188
TTTC
GAA 250 194
CA
CAAC 250 249
AA
ACAG 250 168
TGACA
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HH29 and HH35 were isolated, wax-embedded and sectioned as de-
scribed above. Immunohistochemistry was performed using the anti-
bodies described above.
2.8. Statistics
All data was analysed by parametric tests as the Shapiro-Wilk test
values equal P N 0.05. Levene's testwas used to assess for equality of var-
iances. If P b 0.05, two-tailed assuming equal variances was used to test
for differences between groupmeans on all samples (n ≥ 3) in all exper-
iments (SPSS V21 (SPSS, USA)); P b 0.05 were considered to be
signiﬁcant.
3. Results
3.1. Alteration of haemodynamics results in valve morphogenetic
abnormalities
To investigate the role of abnormal haemodynamics in the develop-
ment of the primordial AV valve and its alignment with other septal
components, OFT-banding of the chick embryonic heart was performed
atHH21 (AVC EC is a localized protrusion of cardiac jelly; atrial and ven-
tricular septation are ongoing). Harvesting was performed at different
stages of post-EMT primordial valve development, at HH26, HH29 and
HH35. Histological analysis revealed that the dysmorphic valve primor-
dial leaﬂets were seen in 19 of the HH29 banded hearts (n= 31) and in
most HH35 banded hearts (n= 6/7), compared to no abnormalities ob-
served in controls at either HH29 (n=37) or HH35 (n= 7) respective-
ly. Morphologically, the valve leaﬂets appeared smaller (arrowhead in
Fig. 1Af compared to d, e) or presented with a nodular thickening at
the distal end of the valve leaﬂet (arrowhead in Fig. 1Ai compared to
g, h) in banded hearts. Also, the hearts which had dysmorphic AV valves
also displayed a ventricular septal defect at HH29 (asterisk in Fig. 1Af)
and HH35 (data not shown). In contrast, the AV cushion was fully
fused with the interventricular septum (IVS) in all controls (Fig. 1Ad, e
for HH29) and HH35 (data not shown). The atrial septum and endocar-
dial cushion at HH26 appeared morphologically normal in banded and
control hearts (n = 5 per group; arrow in Fig. 1Aa–c).
Stereological analysis (at HH29) showed that the primordial AV
valve in controls represented 5.06 ± 0.39% (n = 12), whereas the
valve region in the OFT-banded hearts accounted for 3.46 ± 0.11%
(n = 7), a decrease of 31.62% (two-tailed Student's t-test; P =
0.002; Fig. 1Ba). This was supported by the morphometric measure-
ment of the cushion area and raw primordial valve length at HH29;
a smaller EC area was seen, which was 66% of the size of the controls
(P b 0.001; Fig. 1Bb). Further, shorter primordial MV leaﬂets (Fig. 1Af),
which were 82% of the length of controls (P b 0.001; Fig. 1Bc), were
seen. However, the overall size of the embryo remained comparable
between two groups (Fig. 1Ca, b), as shown by the similar crown
rump length (3.74 ± 0.25 cm and 3.80 ± 0.27 cm in banded and
sham, respectively; P N 0.05). Further, the eye lens diameter presented
0.22± 0.01 cm in banded hearts and 0.23± 0.01 cm in sham (P N 0.05),
and the eye diameter measured 0.95 ± 0.06 cm in banded and 0.97 ±
0.06 cm in sham (P N 0.05) (two-tailed Student's t-test). UponMasson's
Trichrome staining, deposition of collagen was not found in any of the
primordial AV leaﬂets and EC in HH35 control or OFT-banded hearts
(n = 5 per group; arrowhead in Fig. 1Da, b; chick skin positive control
Fig. 1Dc).
3.2. Aberrant expression of TBX20 and aggrecan in endocardial cushion and
valve primordia of HH29 banded hearts
To further characterize the valve phenotype, the TBX20 transcription
factor and its downstream ECM valve markers (aggrecan and periostin)
were examined on serial neighbouring sections throughout HH29control (n = 9) and banded hearts (n = 7). GAPDHwas used as an ex-
perimental control (all hearts expressed normal levels; Fig. 3Ae–f’).
TBX20was expressed intensely in the EC, all four primordial AVvalve
leaﬂets and in part of the atrial and ventricular myocardium in the
controls (Fig. 2Aa, a’), as previously reported [49]. In contrast, a marked
reduction of TBX20 expressionwas seen throughout the heart, including
the cushion and all four primordial valve leaﬂets in banded hearts (n=
5/7; Fig. 2Ab, b’). However, TBX20 expression was still distinct in the
boundary of the EC subjacent to the atrial septum (arrow in Fig. 2Ab’)
and also delineated in the upper lining of the lateral leaﬂet of primordial
MV (arrowhead in Fig. 2Ab’). The qPCR quantiﬁedmRNA level of TBX20
(n = 5 per group) demonstrated a 0.38-fold decrease (two-tailed
Student's t-test; P b 0.001; Fig. 2B).
Consistentwith the literature, punctuate periostinmRNAexpression
was detected throughout the endocardium of both atria and ventricles
as well as the ventricular trabeculae in controls (data not shown) [31,
50]. Expression was further restricted to the endocardial lining of the
atrialis side of the primordial MV septal (Fig. 2Ac, arrow in Fig. 2Ac’)
and lateral (arrowhead in Fig. 2Ac’) leaﬂets. Additionally, abundant
periostin mRNA was observed in the chordae tendinae of the left ven-
tricular AV junction (data not shown). However, periostin mRNA was
not found differentially expressed in the banded hearts by ISH or qPCR
(Fig. 2Ad, d’, B).
At HH29, aggrecan was found localized in the cushion core, subja-
cent to the atrial septum in the controls (Fig. 2Ae, e’), but not in the pos-
terior part of the EC (Fig. 2Ah, h’) or to the valve primordia (Fig. 2Ae, e’,
h, h’). Similarly, aggrecan was also expressed in the central cushion in
the banded hearts (Fig. 2Af, f’). However, ectopic aggrecan expression
was found in ﬁve banded hearts (n = 7) in the lateral part of the TV
cushion (Fig. 2Ai, i’), and in the atrialis side of the primordial MV leaﬂet
(Fig. 2Ag, g’). qPCR revealed no signiﬁcant differences in aggrecan ex-
pression (Fig. 2B).
3.3. Altered expression of shear stress responsive genes KLF2 and EDN1 in
the OFT-banded heart at HH29
To investigate whether an abnormal primordial AV valve is associat-
ed with altered shear stress expression, the expression of known shear-
stress responsive genes (KLF2 and EDN1) [13] were analysed on
neighbouring sections of banded and control hearts. KLF2 in banded
hearts showed amore intense and distinct expression at the endocardi-
al lining of the atrialis side of the primordial MV septal and lateral leaf-
lets (n = 3/7; arrows in Fig. 3Ab, b’) compared to controls (n = 7; Fig.
3Aa, a’). A signiﬁcant 1.15-fold increase of KLF2was shown in the band-
ed hearts (n = 4 per group; two-tailed Student's t-test; P b 0.01; Fig.
3B).
In control hearts, mRNA expression of EDN1was detected in the lin-
ing of the outer curvature of the right and left ventricular myocardium
(n=4; Fig. 3Ac, c’). However, the expression of EDN1was asymmetrical
in one of the banded hearts (n= 1/7), with expression increased in the
RV compact myocardium (arrow in Fig. 3Ad, d’) but was barely discern-
ible in the LV ventricular myocardium (arrowhead in Fig. 3Ad’); the re-
maining banded hearts showed a general decrease of EDN1 expression
in both ventricles (n = 4/7). This was further conﬁrmed by signiﬁcant
downregulation of 0.65 fold of EDN1 mRNA (n = 5; P b 0.001; Fig.
3B). GAPDH was used as a positive control; ubiquitous expression pat-
terns were seen in both control (Fig. 3Ae, e’) and OFT-banded hearts
(n = 7 per group; Fig. 3Af, f’).
3.4. Reduced apoptosis in cushion and primordial AV valves in HH29 OFT-
banded hearts
To provide mechanistic insights into the dysmorphic valve
primordia in banded hearts, an apoptotic study was performed. A clus-
ter pattern of apoptotic cells was found in the EC region subjacent to the
atrial septum in control (Fig. 4Aa’) but not OFT-banded hearts (Fig.
Fig. 1.Defectivemitral valve in OFT-banded hearts. A. Alcian blue stained sections from unoperated (a, d, g), sham (b, e, h) and OFT-banded (c, f, i) hearts at HH26 (n= 5 per group; a–c),
HH29 (n=31 for OFT-banded and n=37 for controls; d–f) andHH35 (n=7; g–i). Valvemorphology at HH26 appeared comparable in all hearts (a–c; denoted by arrow). InOFT-banded
hearts, defective primordial mitral valve appeared either smaller (arrowhead in f) or presentedwith nodular thickening (arrowhead in i) at HH29 and HH35 in comparison to controls (d,
e, g, h; denoted by arrowhead). Asterisk in Af denotes the absence of the interventricular septum (IVS) in the OFT-banded hearts. B. Stereology revealed the primordial AV region was
proportionally smaller in the OFT-banded hearts than controls at HH29 (a). Relative cushion area (b) and relative valve length (c) were smaller and shorter in banded compared to
controls. Student's t-test (two-tailed). Values are mean ± s.e.m. (n = 7 for OFT-banded and n = 12 for controls) (**P b 0.01; ***P b 0.001). C. Representative images of sham (a) and
OFT-banded embryos (b) at HH29, showing the size is similar between both groups. OFT-banded hearts (d) appeared to be larger than the controls (c) at HH29. Arrowhead denotes
the ligature around the outﬂow tract region in the banded hearts. D. Histological analysis using Masson's Trichrome staining revealed no ﬁbrosis (arrowhead indicates blue staining
absent) in the primordial MV septal leaﬂets at HH35 between sham (a) and banded hearts (b) (n = 5). Chick skin shown as a positive control (c). LA, left atrium; LV, left ventricle;
OFT, outﬂow tract; RV, right ventricle; V, ventricle. Scale bars: 250 μm for Aa-i, 1000 μm for Ca-d, 80 μm for Da-c.
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Fig. 2. Expression of early extracellularmatrixmarkers characteristic of valve primordia differentially expressed at HH29 upon alteration of haemodynamics. A. (a–b’) Amarked reduction
of expression of TBX20was observed in the entire endocardial cushion and the atrial and ventricularmyocardium of the banded hearts (b, b’) compared to control (a, a’). However, distinct
TBX20 expressionwas seen in theboundary of the cushion (arrow inb’) and in the upper lining of themitral valve (MV) (arrowhead inb’). (c–d’) No differential expression of periostinwas
found; expression was predominantly detected in the endocardial lining of the MV septal (arrow) and lateral (arrowhead) leaﬂets in both controls (c, c’) and banded hearts (d, d’). (e–i’)
Aggrecan was expressed in the core of the endocardial cushion in control (e, arrow in e’) but not in the posterior part of the cushion (h, arrow in h’). Similar expression was seen in the
central cushion in the banded hearts (f, arrow in f’). However, ectopic expression of aggrecanwas also detected; aggrecanwas seen in the atrialis side of the primordial MV (g, arrow in g’)
and the lateral part of the tricuspid valve cushion on consecutive sections (i, i’). Arrow indicates themost intense expression of aggrecan at the borders of the cushion (i’). n=9 for control
and n = 7 for OFT-banded hearts. a’–i’ are the boxed areas in a–i respectively. Scale bar: 300 μm for Aa–I, 150 μm for Aa’–i’. LA, left atrium; LV, left ventricle; RA, right atrium; RV, right
ventricle. B. Relative expression of early extracellular matrix genes characteristic of valve primordia was quantiﬁed by qPCR at HH29. TBX20 was signiﬁcantly downregulated in the
banded hearts by 0.39 fold (***P b 0.001) compared to controls. Periostin and aggrecan mRNA levels were not signiﬁcantly different between groups. Student's t-test (two-tailed). Data
are mean ± s.e.m. (n = 5).
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primordial MV (Fig. 4Aa”, b”) and TV leaﬂets (Fig. 4Aa”’, b”’) in both
groups.
Themost evident apoptotic regionwas the EC; 4.02±0.56% apopto-
tic cellswere found in control hearts (Fig. 4Aa’), but only 1.69±0.37% in
the banded hearts (two-tailed Student's t-test; P b 0.01; Fig. 4Ab’, B). In
primordial MV septal leaﬂets, 1.40 ± 0.22% of cells in banded hearts(arrow in Fig. 4Ab”) were undergoing apoptosis compared to 2.13 ±
0.16% in controls (Fig. 4Aa”, B; P b 0.05). Further, apoptotic cell numbers
in the right lateral leaﬂet were signiﬁcantly lower in the OFT-banded
hearts (arrowhead in Fig. 4Ab”’), with 1.22±0.22% apoptotic cells com-
pared to 3.12 ± 0.7% in controls (Fig. 4Aa”’, B; P b 0.05). However, the
primordial TV septal (arrow in Fig. 4Ab”’, B) and the primordial MV lat-
eral leaﬂets (arrowhead in Fig. 4Ab”, B) showed a non-signiﬁcant
Fig. 3.Altered shear stress gene expression inOFT-banded hearts. A. An increase of the shear stress responsive genes,KLF2,was detected in the primordialmitral valve endocardial lining of
both septal and lateral leaﬂets (arrows) in banded (b, b’) compared to control hearts (a, a’). In one banded heart (n = 1/7), a noticeable decrease of EDN1 was found in the compact
myocardium of the outer curvature of the left ventricle (d, arrowhead in d’) but an increase was found in the right ventricle (d, arrow in d’). In contrast, EDN1 was uniformly
expressed in the compact myocardium of both ventricles in controls (c, arrow and arrowhead in c’). Experimental control GAPDH showed ubiquitous expression in both control and
banded hearts (e, e’ and f, f’). n = 9 for control and n = 7 for OFT-banded hearts. a’–f’ are the boxed areas in a–f. Scale bar: 300 μm for Aa-f, 150 μm for Aa’–f’. LA, left atrium; LV, left
ventricle; RA, right atrium; RV, right ventricle. B & C. Relative expression of shear stress responsive genes was determined by qPCR in HH29 control and OFT-banded hearts. A
signiﬁcant upregulation of KLF2 was found (1.15 fold) in banded hearts (**P b 0.01) (B). Downregulation of EDN1 by 0.65 fold was found in the OFT-banded hearts (***P b 0.001) (C).
Two-tailed Student's t-test; data indicate mean ± s.e.m. (n = 5).
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(arrow in Fig. 4Aa”’, B and arrowhead in Fig. 4Aa”, B, respectively; P N
0.05). The total apoptotic cells identiﬁed in the primordial valve region
was signiﬁcantly lower in banded hearts (1.53 ± 0.26%) compared to
controls (2.89 ± 0.28%; P b 0.01; Fig. 4B).
3.5. Spatial-temporal expression proﬁles of ECM valve proteins
With regards the expression of ECM proteins during early AV
valvulogenesis, ﬁbrillin-2 has partially been studied within the litera-
ture in the chick [48], whereas the expression of both type III collagen
and tenascin have only been studied in other species [51,52]. Therefore,
immunohistochemical analyses were performed to ﬁll these gaps in
knowledgewith a spatial-temporal expression analyses at crucial stages
of early chick valvulogenesis (HH21, HH26, HH29 and HH35; n= 2 per
stage). Fibrillin-2 was detected at all stages. At HH21, distinct ﬁbrillin-2
immunoreactivity was seen at the endocardial lining of the AVC (Fig.
5a), and at HH26 was restricted to the border of the fused
mesenchymalized EC (Fig. 5b). Positive immunostaining was not seen
in any parts of the HH21 and HH26 developing heart with type III colla-
gen (Fig. 5f, g) and tenascin (Fig. 5k, l). At HH29, stronger staining of
ﬁbrillin-2 was visible in the primordial MV leaﬂet (arrow in Fig. 5c),
with little to no immunoreactivity of ﬁbrillin-2 in the left lateral leaﬂet(arrowhead in Fig. 5c). At HH35, immunolocalisation of ﬁbrillin-2 was
seen in a restricted pattern in both septal and lateral leaﬂets, and in
the chordae tendinae (Fig. 5d). A fairly strong immunostaining of
ﬁbrillin-2 was seen in the central endocardial cushion at this stage (ar-
rowhead in Fig. 5e). Type III collagen was seen to a lesser degree in the
HH29 primordial MV leaﬂet, being more centralized at the tip of the
valve leaﬂet (Fig. 5h). However, strong staining of type III collagen
was found extending from the septal leaﬂet to the chordae tendinae at
HH35 (Fig. 5i), and in the core cushion (Fig. 5j). Positive staining of
tenascin was detected in the core cushion at HH29 (Fig. 5m) and
HH35 (Fig. 5o), but not in the primordial MV leaﬂets (Fig. 5n).3.6. Decreased expression of ECM proteins in primordial AV valve in HH35
OFT-banded hearts
During post-EMT stages, the cushion mesenchyme normally differ-
entiates into valve interstitial cells, the specialized valvular ﬁbroblasts
that express ﬁbrillary collagens, and chondroitin sulfate proteoglycans
[3,34]. Therefore, in order to determine whether valve primordia were
affected at later stage of valve development, type III collagen and
tenascin immunohistochemistrywere performed, aswell as differentia-
tion marker ﬁbrillin-2 [48].
Fig. 4.Apoptosis reduction in the primordial atrioventricular valve region of OFT-banded hearts. A. Apoptotic cells were detected by TUNEL in the endocardial cushion (EC), primordial MV
leaﬂet and primordial TV valve leaﬂet (a & b). Clustering of apoptotic cells was identiﬁed in the EC area (area between atrial septum [AS] and ventricular septum [VS] in a’) in control, but
few apoptotic cells in the EC area (between AS and asterix in b’; small arrows) in banded hearts. Otherwise, the apoptotic cells were found isolated and scattered (small arrows) in the
primordial MV and TV (septal [denoted by arrow] and lateral leaﬂets [arrowheads] in both controls (a” and a”’) and banded (b” and b”’). Asterix in b and b’ denotes the ventricular
septal defect in banded heart. Scale bar: 500 μm for Aa-b, 100 μm for Aa’–a”’ and Bb’–b”’. B. Apoptotic levels in sham and banded hearts at HH29. A decrease of apoptotic cells was
shown in all areas analysed in primordial atrioventricular region (**P b 0.01). This was attributed to a signiﬁcant decrease of apoptosis found in the EC (**P b 0.01), MV septal leaﬂet
and TV lateral leaﬂet (*P b 0.05) in banded hearts compared to controls. No signiﬁcant difference was found in the MV lateral leaﬂet and TV septal leaﬂet (P = 0.73 and P = 0.28
respectively). Student's t-test (two-tailed). Data indicate mean ± s.e.m. (n = 5). AS, atrial septum; EC, endocardial cushion; LA, left atrium; LV, left ventricle; MV, mitral valve; MV lat,
mitral valve lateral leaﬂet; MV sep, mitral valve septal leaﬂet; RA, right atrium; RV, right ventricle; TV, tricuspid valve; TV lat, tricuspid valve lateral leaﬂet; TV sep, tricuspid valve
septal leaﬂet; VS, ventricular septum.
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strongly throughout the leaﬂet in controls (n=5; Fig. 6Aa, c respective-
ly). A noticeable weaker and more diffuse staining of ﬁbrillin-2 (n =
3/5) and type III collagen (n=4/5)was seen in the truncated primordi-
al MV leaﬂets in the OFT-banded hearts (Fig. 6Ab, d). Likewise, a reduc-
tion of type III collagen (n = 4/5) was seen in the chordae tendinae in
the banded hearts (Fig. 6Af) when compared to controls (Fig. 6Ae). Sim-
ilarly, a positive staining was seen in the central endocardial cushion
area subjacent to the atrial septum with zonal restriction of ﬁbrillin-2
in controls (Fig. 6Ba), with decreased immunolocalisation in the core
cushion of banded hearts (n = 3/5; arrow in Fig. 6Bb). The positive
staining of type III collagenwas located in the central cushion in controls
(arrow in Fig. 6Bc). In contrast, little to no immunoreactivity of type III
collagen was observed in the OFT-banded hearts (n = 4/5; arrowheaddenotes equivalent region of the cushion in Fig. 6Bc, d). Lastly, tenascin
staining was in the centre of the cushion of controls (Fig. 6Be) but re-
duced in all banded hearts (n=5; arrow in Fig. 6Bf). The ﬂuorescent in-
tensitywas further quantiﬁed in the primordialMV leaﬂets in ﬁbrillin-2,
type III collagen and tenascin (Fig. 6C; n = 5). The average grey level of
ﬁbrillin-2 was 50.48 ± 1.71 in controls but 34.11 ± 8.02 in banded
hearts, a 32.4% decrease of ﬂuorescent signal. However, this reduction
was not signiﬁcant (P N 0.05). A non-signiﬁcant 30.4% decrease of ﬂuo-
rescence intensity was seen for tenascin, where banded hearts and con-
trol presented 16.1 ± 0.63 and 23.48 ± 3.14 respectively. The
ﬂuorescence intensity of type III collagen was 57.31 ± 6.39 in controls
and 34.37 ± 3.92 in banded hearts, a signiﬁcant reduction of 40%
(two-tailed Student's t-test; P b 0.05). In order to support the decreased
expression of these ECM proteins, mRNA level was quantitated by qPCR
Fig. 5.Cardiac spatial-temporal expression proﬁle of ﬁbrillin-2, type III collagen and tenascin. Chick heartswere isolated atHH21 (a, f, k), HH26 (b, g, l), HH29 (c, h,m) andHH35 (d, e, i, j, n,
o), with staining for ﬁbrillin-2 (a–e), type III collagen (f–j) and tenascin (k–o). Fibrillin-2was expressed in the endocardium lining at the atrioventricular canal (AVC) at HH21 (a), whereas
staining for type III collagen and tenascinwas not observed at theAVC (arrows in f & k respectively) or in any parts of the developing heart besides the pharyngeal arches (arrowhead in k).
At HH26, only ﬁbrillin-2 was seen at the endocardial lining of the cushion mesenchyme (b); type III collagen and tenasin were negative (arrow in g & l). At HH29, ﬁbrillin-2 and type III
collagenwere observed in the primordialmitral valve (MV) septal leaﬂet (arrow in c & h respectively; arrowhead in c denotes negative lateral leaﬂet). Tenascin expressionwas localized to
the endocardial cushion (EC) atHH29 (arrowhead inm). AtHH35, ﬁbrillin-2 (d) and type III collagen (i) demonstrated positive staining in the primordialMV leaﬂet, with themost intense
immunostaining seen in the chordae tendinae (arrow). Staining of tenascin remained negative in the primordial MV septal and lateral leaﬂets (arrow and arrowhead in n respectively).
Widespread expression of ﬁbrillin-2 (arrowhead in e) and type III collagen (arrowhead in j)was also observed in the central cushion. Tenascin expressionwas only seen in the cushion (o).
A, atria; IVS, interventricular septum; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle; V, ventricle; n = 2 per stage. Scale bar: 120 μm.
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downregulation of 1.06 and 1.26 fold (n = 4 per group; two-tailed
Student's t-test; P b 0.05; Fig. 6D). Further, COL3A1 and TGM2 demon-
strated a signiﬁcant downregulation of 1.32 and 1.85 fold in banded
hearts (n = 4 per group; P b 0.01; Fig. 6D).
3.7. Morphologically normal endocardial cushions and atrial septation in
HH26 OFT-banded hearts
Atrial septation was seen to be morphologically normal in banded
hearts (n= 5), a processwhich completes aroundHH24 [28]. However,
the studies described above suggested that the defective valve
primordia at HH29 and HH35 might form from a deformed EC. In
order to examine this, ISH was performed on markers of the EC area
on neighbouring sections at HH26 (post-EMT).
As expected, versican was expressed in the mesenchymal cap of the
atrial septum that fusedwith the AV cushions in both controls (arrow in
Fig. 7A, A’) and OFT-banded hearts (n = 5 per group; Fig. 7B, B’),
conﬁrming normal atrial septation had occurred [53]. TBX20 was
strongly expressed in the EC and part of the ventricular myocardium
(Fig. 7C, C’) of controls. Less intense TBX20 expression was detected on
serial sections in two of the banded hearts analysed (2/5; Fig. 7E, E’)
compared to controls. Otherwise, TBX20 expression was found normal
(3/5; Fig. 7D, D’). At HH26, abundant periostin mRNA was detected in
the endothelial lining and adjacent tissue of the AV cushions in controls
(Fig. 7F, F’) and OFT-banded hearts (n = 5; Fig. 7G, G’). Aggrecan ex-
pression was restricted to the lateral part of the left side of the endocar-
dial cushion in both groups (arrow in Fig. 7H, H’, I, I’).
4. Discussion
Valve defects constitute an important medical issue challenging our
society. Though valve developmental defects may initially be asymp-
tomatic, they are often progressive and contribute to valve disease
later in life. Abnormal valves often display dysregulation of ECM pro-
teins such as collagens and glycosaminoglycans, as seen in patients
with myxomatous mitral valve and mitral valve prolapse [54].Structural changes of ECM are associated with the aberrant re-expres-
sion of early valve mesenchymal markers, implying the reactivation of
the fetal gene program that is normally quiescent in adulthood [55,56].
Recently, valvulogenesis has been shown to be haemodynamically
dependent, with occlusion of blood at either the inﬂow or outﬂow
resulting in absent AV valve in zebraﬁsh [10]. We delineated the role
of abnormal haemodynamics in the developing primordial mitral AV
valve and its alignment with other septal components at critical stages
of chamber septation and valve development. A ligature was placed
around the HH21 outﬂow region and harvested at HH26 (atrial
septation complete, post-EMTwith fusion of superior and inferior cush-
ions), HH29 (fused cushionsmature, primordial AV valve elongates and
ventricular septation complete) and HH35 (remodelling). In this OFT-
banding model, alteration of haemodynamics has previously been
shown to result in increased ventricular pressure and wall shear stress,
as well as higher peak blood ﬂow velocity in the OFT region [57–60].
Morphologically, the OFT-banded hearts exhibited right-shifted posi-
tion of the OFT and appeared to be approximately 1.77 times larger
than controls by HH29 (unpublished data; Fig. 1Cc, d), An enlarged
heart is a characteristic of pressure-overloaded embryonic hearts [21,
58,61]. However, the crown rump length and eye diameter (as de-
scribed here) together with cardiac output and heart rate [57,62],
remained unchanged in this model.
The AV endocardial cushion was structurally normal at HH26 but
dysmorphic and truncated primordial mitral valves were seen at
HH29 and HH35, with a smaller primordial valve region. AV valves
were generally immature in another altered haemodynamic model (vi-
telline vein clip) [20], with the tricuspid valve morphologically abnor-
mal upon banding [21].
TBX20 is important in promoting EC cell proliferation andmigration,
and ECM gene expression in vitro [43,44]. In addition, Tbx20 plays a role
in ECmaturation and valve elongation [41]. In normal development, fu-
sion of the superior and inferior AV cushions and their subsequent
union with the dorsal mesenchymal cap of the primary atrial septum
has occurred by HH26 [26,63]. TBX20 expression was analysed in
order to elucidate if it was differentially expressed in the morphologi-
cally normal OFT-banded HH26 early valve primordia. Interestingly,
Fig. 6.Decreased expression of extracellularmatrixmarkers characteristic of valvulogenesis inHH35OFT-banded hearts. A. Decreased and amore diffuse staining ofﬁbrillin-2 (arrow in b)
in the primordial MV septal leaﬂet compared to controls (a). A similar reduction of type III collagen expression was also seen in the septal leaﬂet (arrow in d) and the chordae tendinae
(arrow in f) in OFT-banded compared to controls (c and e, respectively) (n = 5). B. Positive expression of ﬁbrillin-2 (a), type III collagen (c) and tenascin (e) in the endocardial cushion
(denoted by an arrow) seen in the controls was decreased in banded hearts (arrow in b, d and f respectively; asterix denotes ventricular septal defect). Arrowhead in c and d denote
equivalent region of the endocardial cushion between controls and banded hearts (n = 5). C. The ﬂuorescence signal intensity of the primordial mitral valve leaﬂet was semi-
quantiﬁed using MetaExpress software, with a signiﬁcant reduction of ﬂuorescence intensity for type III collagen (two-tailed Student's t-test; P b 0.05; n = 5). Scale bar in Aa 120 μm;
same magniﬁcation for all panels in A&B. D. qPCR showed a 1.06- and 1.26 downregulation of ﬁbrillin 2 and tenascin C in HH35 banded hearts. A signiﬁcant decrease was seen in type
III collagen and TGM2 by 1.32 and 1.85 fold, respectively (two-tailed Student's t-test; P b 0.01; n = 3). Data represent means ± sem. AS, atrial septum; AVJ; average grey level. LA, left
atrium; LV, left ventricle; RA, right atrium; RV, right ventricle; VS, ventricular septum.
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creased expression of TBX20was observed in the EC region in two of the
ﬁve banded hearts (asterisk in Fig. 7E, E’). Periostin and aggrecan were
not differentially expressed in neighbouring sections. Periostin and
aggrecan have been found downregulated in the Tbx20 knockdown
[41]. The decrease in expression of TBX20 (−0.39 fold) in our study at
HH29 suggests alteration of haemodynamics leads to reduced TBX20
and concurrent ectopic expression of its target aggrecan,which together
engendered AV valve elongation defects. The data described here sup-
ports the hypothesis that TBX20 acts upstream of aggrecan. Aggrecan
is one of the main chondroitin sulfate proteoglycan constituents of the
spongiosa layer in avian valves, and is required to withstand compres-
sive forces against blood ﬂow [32,43], and reportedly has a role in
valve cell differentiation [44,64].
Periostin has been previously reported for its multifaceted role in
cell migration and differentiation; it promotes differentiation of
prevalvular mesenchymal cells into collagen-producing ﬁbroblastic
cells termed ‘valve interstitial cells’ while repressing transformationinto myocyte lineages [31,44]. Periostin is also able to interact with
other ECM components such as collagen, tenascin and ﬁbronectin [65–
67]. Interestingly, although periostin was normally expressed, collagen
III and tenascinwere found to be differentially expressed. It can be spec-
ulated that mRNA downregulation of one transcript variant might lead
to a compensatory upregulation of another variant upon altered
haemodynamics, as differential periostin isoform expression proﬁles
were observed in periostin-null mice after myocardial infarction [68,
69].
Remodelling of the AVC and OFT tissues occur through apoptosis
[70]. Clustering of apoptotic cells is involved in cushion differentiation
and outgrowth, as evidenced by a lack of apoptosis and overabundant
cushions in the Nf-1 null mouse [71,72]. In contrast, our study showed
a decrease in apoptosis in the primordial AV region and smaller cush-
ions in banded hearts. This suggests normal levels of apoptosis are re-
quired for EC differentiation [72]. In addition, the regulatory factors
Bmp4, Bmp2 andMsx2 have been associated with cells undergoing apo-
ptosis, and hence differentiation [73]. As Bmp2 is considered to be a key
Fig. 7. Normal atrial septation with mild differential expression of an endocardial cushion marker in haemodynamically altered hearts at HH26. A–B’: Normal atrial septation
(mesenchymal cap [arrow] fused with the AV endocardial cushions [asterix]) was seen, along with expected immunoreactivity for versican, in control (A, A’) and banded (B, B’) hearts.
C–E’: Strong TBX20 expression was observed in the entire endocardial cushion area in controls (C, C’) and in three banded hearts (D, D’). In contrast, decreased expression in the
endocardial cushions in two banded hearts (E, E’) was seen compared to controls (C, C’). The endocardial cushion area is denoted by an asterisk (C’, D’, E’). F–G’: Periostin was
intensely expressed in the endocardial lining of the cushion in both control (F, F’) and banded hearts (G, G’) (arrow in F’ and G’). H–I’: Expression of aggrecan was seen in the subatrial
region of the endocardial cushion in both control (H, arrow in H’) and OFT-banded hearts (I, arrow in I’) n = 5 per group. A’–I’ are the boxed areas in A–I respectively. LA, left atrium;
RA, right atrium; RV, right ventricle; V, ventricle.
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thy of future investigation.
At a later stage of valvulogenesis, cushion mesenchyme is normally
differentiated into valve interstitial cells, cells which express genes
that encode ﬁbrillary collagens, chondroitin sulfate proteoglycans and
elastin, which are associated with stratiﬁed ECM of mature valves [3,
34,75]. Upon abnormal blood ﬂow, the differentiation process was pre-
dicted to be affected in HH35 banded hearts, with weaker expression of
COL3A, TNC and FBN2 mRNA. Fibrillin-2 is known to be expressed in a
subset of endothelial cells competent to transdifferentiate into cushion
mesenchyme and connective tissue ﬁbroblasts of the valve leaﬂets[48]. Also, FBN2 transcripts accumulate prior to tissue differentiation,
decreasing rapidly thereafter during development [76]. We speculate
that the decrease of ﬁbrillin-2 staining and its mRNA in our study sug-
gests differentiation failed to occur. Similarly, in patients with mitral
valve prolapse syndrome, a more diffuse and weaker staining pattern
of ﬁbrillin and type III collagen were seen in the area of myxoid degen-
eration of diseased MV leaﬂets [77]. Further, part of the EC is differenti-
ated into valve leaﬂets and chordae tendinae during normal
development, and the attachment of the papillary muscle to valve leaf-
lets without chordae tendinae was seen in human fetal hearts at weeks
5–19 week, when differentiation failed to occur [78,79]. Additionally,
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(TGM2), which encodes the TG2 ECM cross-linking protein, could lead
to the decrease of the ECM proteins ﬁbrillin-2 and type III collagen.
TG2 has been reported for its role in ECM condensation and organiza-
tion by interacting with ﬁlamin-A and serotonin [5]. TG2 has also been
implicated in osteoblast differentiation, with its expression deﬁning
the border of differentiation; TG2 protein expression was absent in
the cushion but present in the adjacentmyocardiumprior to cushion fu-
sion [22,80]. It was also in almost all the interstitial cells following cush-
ion fusion (HH27) and maturation (HH35) [22]. Downregulation of
TGM2 in our study suggests aberrant differentiation of the cushionmes-
enchyme, indicating that the proteolytically activate protein could be an
area of future interest.
Normalﬂuid ﬂow in the heart is important in shaping the EC into the
developing cardiac valve leaﬂets [10,11]. Knockdown of trpv4 (encodes
a mechanotransduction protein), which is upstream of the shear stress
responsive gene klf2a, led to the development of dysmorphic valves in
zebraﬁsh [81]. In addition, the klf2a null mutant zebraﬁsh displayed an
array of valvular phenotypes, attributed to cell disorganization at the
AVC and impaired ﬁbronectin synthesis [12]. In addition, laminar
shear stress is involved in endothelial differentiation [82,83]. In the
OFT-banded heart, higher peak and end diastolic interventricular pres-
sure was seen [18,57,58]. Further, increased peak blood ﬂow velocities
near the banding site and regurgitation around the AV region were
found at HH27 [17,84]. Alteration of wall shear stresses, as a result of
changes of blood ﬂow pattern, are known to alter shear stress respon-
sive genes KLF2 and EDN1 [85], as did altering haemodynamics in the
venous clip model [86]. Here, we support the notion of pressure
overloading upon OFT-banding by showing the up- and down-regula-
tion of the KLF2 and EDN1 shear stress genes respectively, in banded
hearts. This might lead to aberrant differentiation of the EC cushion
and decreased expression of the ECM proteins in the valve leaﬂet and
hence a maturation arrest in valve development.
5. Concluding remarks
Fetal valvulogenesis consists of two main phases: EMT and post-
EMT maturation, with the latter phase involving the remodelling of
the cushion into mature valve leaﬂets. Defects arising in the post-EMT
valve were associated with aberrant expression of early mesenchymal
markers and dysregulation of ECMproteins such asﬁbrillin and collagen
which were previously seen in patients with mitral valve prolapse syn-
drome, with the underlying mechanism remaining poorly understood.
In this study we show aberrant expression of TBX20, aggrecan and
shear stress responsive genes upon abnormal haemodynamics. The de-
crease in apoptosis and the dysregulation of ECM proteins indicate the
mechanism. Together, our data suggest that failure of differentiation of
cushion mesenchyme into valvular interstitial cells caused by abnormal
blood ﬂow, is a potential mechanism to give rise to valve defects post-
EMT. Therefore, this study provides new insights into potential aetiol-
ogies of human congenital valve malformations.
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